Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Volatility in retirement index funds can affect withdrawals. Explore causes and strategies to smooth risk through diversified allocations.
23,649 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Anthropic and Airbnb are placing big bets on New York City, expanding footprints and hiring aggressively while critic...
Choosing between broad healthcare stability and biotech growth can shape your portfolio. Learn how XLV and IBBQ diffe...
A founder sold a meaningful chunk of stock, but does that signal trouble or a routine liquidity move? This article br...
Meta quietly positions itself as the strongest mega-cap alternative this summer, leveraging ad momentum and a new AI ...
If Vertex pursues Crinetics, what would it mean for the stock? This article breaks down potential value, risks, and t...
NIO delivered a surprising Q4 2025 GAAP profit and outlined a 2026 path to positive non-GAAP earnings, supported by m...
Aehr Test Systems faces a pivotal Q4 print after the market closes, with AI burn-in demand and bookings in focus as t...
Bitcoin and Ethereum jumped after cooler-than-expected U.S. inflation data, while Japan’s Upper House committee advan...
AMD narrows the AI accelerator gap with NVIDIA as cloud providers diversify their AI infrastructure, signaling a shif...
CoreWeave has dropped substantially from its 52-week peak, leaving investors debating whether the bounce is coming or...
AI-driven capex is lifting lithography demand, placing ASML at the center of a multiyear upgrade cycle. This piece ex...